The global Circulating Tumor Cell market size was valued at USD 689.6 million in 2023 and is forecast to a readjusted size of USD 1148.6 million by 2030 with a CAGR of 7.6% during review period.
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, ²Ï¾±²¹²µ±ð²Ôï¼Ô²»å²Ô²¹²µ±ð²Ô）, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.
This report includes an overview of the development of the Circulating Tumor Cell industry chain, the market status of Breast Cancer (CTC Enrichment, CTC Detection), Prostate Cancer (CTC Enrichment, CTC Detection), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Circulating Tumor Cell.
Regionally, the report analyzes the Circulating Tumor Cell markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Circulating Tumor Cell market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Circulating Tumor Cell market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Circulating Tumor Cell industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., CTC Enrichment, CTC Detection).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Circulating Tumor Cell market.
Regional Analysis: The report involves examining the Circulating Tumor Cell market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Circulating Tumor Cell market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Circulating Tumor Cell:
Company Analysis: Report covers individual Circulating Tumor Cell players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Circulating Tumor Cell This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Breast Cancer, Prostate Cancer).
Technology Analysis: Report covers specific technologies relevant to Circulating Tumor Cell. It assesses the current state, advancements, and potential future developments in Circulating Tumor Cell areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Circulating Tumor Cell market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Circulating Tumor Cell market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
CTC Enrichment
CTC Detection
CTC Analysis
Market segment by Application
Breast Cancer
Prostate Cancer
Colorectal Cancer
Others
Market segment by players, this report covers
Menarini-Silicon Biosystems
²Ï¾±²¹²µ±ð²Ôï¼Ô²»å²Ô²¹²µ±ð²Ô）
Clearbridge Biomedics
Celsee
Fluidigm
ApoCell
Greiner Bio-one
Advanced Cell Diagnostics
Aviva Biosciences
Fluxion Biosciences
Sysmex
Epic Sciences
Cynvenio
CytoTrack
Ikonisys
Vortex BioSciences
Gilupi
Biocept
ScreenCell
ANGLE
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Circulating Tumor Cell product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Circulating Tumor Cell, with revenue, gross margin and global market share of Circulating Tumor Cell from 2019 to 2024.
Chapter 3, the Circulating Tumor Cell competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Circulating Tumor Cell market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Circulating Tumor Cell.
Chapter 13, to describe Circulating Tumor Cell research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Circulating Tumor Cell
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Circulating Tumor Cell by Type
1.3.1 Overview: Global Circulating Tumor Cell Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Circulating Tumor Cell Consumption Value Market Share by Type in 2023
1.3.3 CTC Enrichment
1.3.4 CTC Detection
1.3.5 CTC Analysis
1.4 Global Circulating Tumor Cell Market by Application
1.4.1 Overview: Global Circulating Tumor Cell Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Breast Cancer
1.4.3 Prostate Cancer
1.4.4 Colorectal Cancer
1.4.5 Others
1.5 Global Circulating Tumor Cell Market Size & Forecast
1.6 Global Circulating Tumor Cell Market Size and Forecast by Region
1.6.1 Global Circulating Tumor Cell Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Circulating Tumor Cell Market Size by Region, (2019-2030)
1.6.3 North America Circulating Tumor Cell Market Size and Prospect (2019-2030)
1.6.4 Europe Circulating Tumor Cell Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Circulating Tumor Cell Market Size and Prospect (2019-2030)
1.6.6 South America Circulating Tumor Cell Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Circulating Tumor Cell Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Menarini-Silicon Biosystems
2.1.1 Menarini-Silicon Biosystems Details
2.1.2 Menarini-Silicon Biosystems Major Business
2.1.3 Menarini-Silicon Biosystems Circulating Tumor Cell Product and Solutions
2.1.4 Menarini-Silicon Biosystems Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Menarini-Silicon Biosystems Recent Developments and Future Plans
2.2 ²Ï¾±²¹²µ±ð²Ôï¼Ô²»å²Ô²¹²µ±ð²Ô）
2.2.1 ²Ï¾±²¹²µ±ð²Ôï¼Ô²»å²Ô²¹²µ±ð²Ô） Details
2.2.2 ²Ï¾±²¹²µ±ð²Ôï¼Ô²»å²Ô²¹²µ±ð²Ô） Major Business
2.2.3 ²Ï¾±²¹²µ±ð²Ôï¼Ô²»å²Ô²¹²µ±ð²Ô） Circulating Tumor Cell Product and Solutions
2.2.4 ²Ï¾±²¹²µ±ð²Ôï¼Ô²»å²Ô²¹²µ±ð²Ô） Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 ²Ï¾±²¹²µ±ð²Ôï¼Ô²»å²Ô²¹²µ±ð²Ô） Recent Developments and Future Plans
2.3 Clearbridge Biomedics
2.3.1 Clearbridge Biomedics Details
2.3.2 Clearbridge Biomedics Major Business
2.3.3 Clearbridge Biomedics Circulating Tumor Cell Product and Solutions
2.3.4 Clearbridge Biomedics Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Clearbridge Biomedics Recent Developments and Future Plans
2.4 Celsee
2.4.1 Celsee Details
2.4.2 Celsee Major Business
2.4.3 Celsee Circulating Tumor Cell Product and Solutions
2.4.4 Celsee Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Celsee Recent Developments and Future Plans
2.5 Fluidigm
2.5.1 Fluidigm Details
2.5.2 Fluidigm Major Business
2.5.3 Fluidigm Circulating Tumor Cell Product and Solutions
2.5.4 Fluidigm Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Fluidigm Recent Developments and Future Plans
2.6 ApoCell
2.6.1 ApoCell Details
2.6.2 ApoCell Major Business
2.6.3 ApoCell Circulating Tumor Cell Product and Solutions
2.6.4 ApoCell Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 ApoCell Recent Developments and Future Plans
2.7 Greiner Bio-one
2.7.1 Greiner Bio-one Details
2.7.2 Greiner Bio-one Major Business
2.7.3 Greiner Bio-one Circulating Tumor Cell Product and Solutions
2.7.4 Greiner Bio-one Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Greiner Bio-one Recent Developments and Future Plans
2.8 Advanced Cell Diagnostics
2.8.1 Advanced Cell Diagnostics Details
2.8.2 Advanced Cell Diagnostics Major Business
2.8.3 Advanced Cell Diagnostics Circulating Tumor Cell Product and Solutions
2.8.4 Advanced Cell Diagnostics Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Advanced Cell Diagnostics Recent Developments and Future Plans
2.9 Aviva Biosciences
2.9.1 Aviva Biosciences Details
2.9.2 Aviva Biosciences Major Business
2.9.3 Aviva Biosciences Circulating Tumor Cell Product and Solutions
2.9.4 Aviva Biosciences Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Aviva Biosciences Recent Developments and Future Plans
2.10 Fluxion Biosciences
2.10.1 Fluxion Biosciences Details
2.10.2 Fluxion Biosciences Major Business
2.10.3 Fluxion Biosciences Circulating Tumor Cell Product and Solutions
2.10.4 Fluxion Biosciences Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Fluxion Biosciences Recent Developments and Future Plans
2.11 Sysmex
2.11.1 Sysmex Details
2.11.2 Sysmex Major Business
2.11.3 Sysmex Circulating Tumor Cell Product and Solutions
2.11.4 Sysmex Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Sysmex Recent Developments and Future Plans
2.12 Epic Sciences
2.12.1 Epic Sciences Details
2.12.2 Epic Sciences Major Business
2.12.3 Epic Sciences Circulating Tumor Cell Product and Solutions
2.12.4 Epic Sciences Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Epic Sciences Recent Developments and Future Plans
2.13 Cynvenio
2.13.1 Cynvenio Details
2.13.2 Cynvenio Major Business
2.13.3 Cynvenio Circulating Tumor Cell Product and Solutions
2.13.4 Cynvenio Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Cynvenio Recent Developments and Future Plans
2.14 CytoTrack
2.14.1 CytoTrack Details
2.14.2 CytoTrack Major Business
2.14.3 CytoTrack Circulating Tumor Cell Product and Solutions
2.14.4 CytoTrack Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 CytoTrack Recent Developments and Future Plans
2.15 Ikonisys
2.15.1 Ikonisys Details
2.15.2 Ikonisys Major Business
2.15.3 Ikonisys Circulating Tumor Cell Product and Solutions
2.15.4 Ikonisys Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Ikonisys Recent Developments and Future Plans
2.16 Vortex BioSciences
2.16.1 Vortex BioSciences Details
2.16.2 Vortex BioSciences Major Business
2.16.3 Vortex BioSciences Circulating Tumor Cell Product and Solutions
2.16.4 Vortex BioSciences Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Vortex BioSciences Recent Developments and Future Plans
2.17 Gilupi
2.17.1 Gilupi Details
2.17.2 Gilupi Major Business
2.17.3 Gilupi Circulating Tumor Cell Product and Solutions
2.17.4 Gilupi Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Gilupi Recent Developments and Future Plans
2.18 Biocept
2.18.1 Biocept Details
2.18.2 Biocept Major Business
2.18.3 Biocept Circulating Tumor Cell Product and Solutions
2.18.4 Biocept Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Biocept Recent Developments and Future Plans
2.19 ScreenCell
2.19.1 ScreenCell Details
2.19.2 ScreenCell Major Business
2.19.3 ScreenCell Circulating Tumor Cell Product and Solutions
2.19.4 ScreenCell Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 ScreenCell Recent Developments and Future Plans
2.20 ANGLE
2.20.1 ANGLE Details
2.20.2 ANGLE Major Business
2.20.3 ANGLE Circulating Tumor Cell Product and Solutions
2.20.4 ANGLE Circulating Tumor Cell Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 ANGLE Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Circulating Tumor Cell Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Circulating Tumor Cell by Company Revenue
3.2.2 Top 3 Circulating Tumor Cell Players Market Share in 2023
3.2.3 Top 6 Circulating Tumor Cell Players Market Share in 2023
3.3 Circulating Tumor Cell Market: Overall Company Footprint Analysis
3.3.1 Circulating Tumor Cell Market: Region Footprint
3.3.2 Circulating Tumor Cell Market: Company Product Type Footprint
3.3.3 Circulating Tumor Cell Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Circulating Tumor Cell Consumption Value and Market Share by Type (2019-2024)
4.2 Global Circulating Tumor Cell Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Circulating Tumor Cell Consumption Value Market Share by Application (2019-2024)
5.2 Global Circulating Tumor Cell Market Forecast by Application (2025-2030)
6 North America
6.1 North America Circulating Tumor Cell Consumption Value by Type (2019-2030)
6.2 North America Circulating Tumor Cell Consumption Value by Application (2019-2030)
6.3 North America Circulating Tumor Cell Market Size by Country
6.3.1 North America Circulating Tumor Cell Consumption Value by Country (2019-2030)
6.3.2 United States Circulating Tumor Cell Market Size and Forecast (2019-2030)
6.3.3 Canada Circulating Tumor Cell Market Size and Forecast (2019-2030)
6.3.4 Mexico Circulating Tumor Cell Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Circulating Tumor Cell Consumption Value by Type (2019-2030)
7.2 Europe Circulating Tumor Cell Consumption Value by Application (2019-2030)
7.3 Europe Circulating Tumor Cell Market Size by Country
7.3.1 Europe Circulating Tumor Cell Consumption Value by Country (2019-2030)
7.3.2 Germany Circulating Tumor Cell Market Size and Forecast (2019-2030)
7.3.3 France Circulating Tumor Cell Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Circulating Tumor Cell Market Size and Forecast (2019-2030)
7.3.5 Russia Circulating Tumor Cell Market Size and Forecast (2019-2030)
7.3.6 Italy Circulating Tumor Cell Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cell Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Circulating Tumor Cell Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Circulating Tumor Cell Market Size by Region
8.3.1 Asia-Pacific Circulating Tumor Cell Consumption Value by Region (2019-2030)
8.3.2 China Circulating Tumor Cell Market Size and Forecast (2019-2030)
8.3.3 Japan Circulating Tumor Cell Market Size and Forecast (2019-2030)
8.3.4 South Korea Circulating Tumor Cell Market Size and Forecast (2019-2030)
8.3.5 India Circulating Tumor Cell Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Circulating Tumor Cell Market Size and Forecast (2019-2030)
8.3.7 Australia Circulating Tumor Cell Market Size and Forecast (2019-2030)
9 South America
9.1 South America Circulating Tumor Cell Consumption Value by Type (2019-2030)
9.2 South America Circulating Tumor Cell Consumption Value by Application (2019-2030)
9.3 South America Circulating Tumor Cell Market Size by Country
9.3.1 South America Circulating Tumor Cell Consumption Value by Country (2019-2030)
9.3.2 Brazil Circulating Tumor Cell Market Size and Forecast (2019-2030)
9.3.3 Argentina Circulating Tumor Cell Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cell Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Circulating Tumor Cell Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Circulating Tumor Cell Market Size by Country
10.3.1 Middle East & Africa Circulating Tumor Cell Consumption Value by Country (2019-2030)
10.3.2 Turkey Circulating Tumor Cell Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Circulating Tumor Cell Market Size and Forecast (2019-2030)
10.3.4 UAE Circulating Tumor Cell Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Circulating Tumor Cell Market Drivers
11.2 Circulating Tumor Cell Market Restraints
11.3 Circulating Tumor Cell Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Circulating Tumor Cell Industry Chain
12.2 Circulating Tumor Cell Upstream Analysis
12.3 Circulating Tumor Cell Midstream Analysis
12.4 Circulating Tumor Cell Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Menarini-Silicon Biosystems
²Ï¾±²¹²µ±ð²Ôï¼Ô²»å²Ô²¹²µ±ð²Ô）
Clearbridge Biomedics
Celsee
Fluidigm
ApoCell
Greiner Bio-one
Advanced Cell Diagnostics
Aviva Biosciences
Fluxion Biosciences
Sysmex
Epic Sciences
Cynvenio
CytoTrack
Ikonisys
Vortex BioSciences
Gilupi
Biocept
ScreenCell
ANGLE
Ìý
Ìý
*If Applicable.
